Seminars in Fetal & Neonatal Medicine
Volume 14, Issue 4 , Pages 190-199 , August 2009

Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis

  • Ken B. Waites

      Affiliations

    • Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • Corresponding Author InformationCorresponding author. Departmentof Pathology, University of Alabama at Birmingham, WP 230, 619 19th Street South, Birmingham, AL 35249, USA. Tel.: +1 205 934 4960; fax: +1 205 975 4468.
  • ,
  • Robert L. Schelonka

      Affiliations

    • Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • ,
  • Li Xiao

      Affiliations

    • Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • ,
  • Peta L. Grigsby

      Affiliations

    • Division of Reproductive Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA
  • ,
  • Miles J. Novy

      Affiliations

    • Division of Reproductive Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA

References 

  1. Waites KB, Katz B, Schelonka RL. Mycoplasmas and Ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757–789
  2. Schelonka RL, Katz B, Waites KB, Benamin DK. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J. 2005;24:1033–1039
  3. Schelonka RL, Waites KB. Ureaplasma infection and neonatal lung disease. Semin Perinatol. 2007;31:2–9
  4. Robertson A, Stemke GW, Davis JW, et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974). Int J Syst Evol Microbiol. 2002;52:587–597
  5. Glass I, Lefkowitz E, Glass S, Heiner CR, Chen EY, Cassell GH. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature. 2000;407(6805):757–762
  6. Ursi D, Ursi P, Ieven M, Docx M, Van Reempts P, Pattyn SR. Congenital pneumonia due to Mycoplasma pneumoniae. Arch Dis Child. 1995;72:F118–F120
  7. Jensen S. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol. 2004;18:1–11
  8. Luki N, Lebel P, Boucher M, Doray B, Turgeon J, Brousseau R. Comparison of polymerase chain reaction assay with culture for detection of genital Mycoplasmas in perinatal infections. Eur J Clin Microbiol Infect Dis. 1998;17:255–263
  9. Blanchard A, Hamrick W, Duffy L, Baldus K, Cassell GH. Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid. Clin Infect Dis. 1993;17(Suppl. 1):S272–S279
  10. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993;36:795–808
  11. Andrews WW, Goldenberg RL, Hauth C, Cliver SP, Conner M, Goepfert AR. Endometrial microbial colonization and plasma cell endometritis after spontaneous or indicated preterm versus term delivery. Am J Obstet Gynecol. 2005;193(3 Pt 1):739–745
  12. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis. 1983;10(4 Suppl.):294–302
  13. Gerber S, Vial Y, Hohlfeld P, Witkin SS. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis. 2003;187:518–521
  14. DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE. 2008;3:e3056
  15. Novy M, Duffy L, Axthelm M, et al. Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery and pneumonia in rhesus macaques. Reprod Sci 2008:1--15. doi:10.1177/1933719108325508.
  16. Moss T, Nitsos I, Ikegami M, Jobe AH, Newnham P. Experimental intrauterine Ureaplasma infection in sheep. Am J Obstet Gynecol. 2005;192:1179–1186
  17. Moss T, Knox CL, Kallapur SG, et al. Experimental amniotic fluid infection in sheep: effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep. Am J Obstet Gynecol. 2008;198:122;e1–8
  18. Simhan HN, Caritis SN, Krohn MA, Martinez de Teada B, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 2003;189:560–567
  19. Hillier SL, Martius , Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case–control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988;319:972–978
  20. Cicinelli E, De Ziegler D, Nicoletti R, et al. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril. 2008;89:677–684
  21. Cassell GH, Waites KB, Crouse DT. Mycoplasmal infections. In:  Remington S,  Klein O editor. Infectious diseases of the fetus and newborn infant. 5th ed.. Philadelphia: W.B. Saunders; 2001;p. 733–767
  22. Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth C, Cassell GH. Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum. Obstet Gynecol. 1995;85:509–514
  23. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007;(1):CD000262
  24. Morency AM, Buold E. The effect of second-trimester antibiotic therapy on the rate of preterm birth. J Obstet Gynaecol Can. 2007;29:35–44
  25. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008;(2):CD006178
  26. Kenyon SL, Taylor D, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 2001;357(9261):979–988
  27. Sadowsky DW, Colgin LM, Duffy LB, Waites KB, Gravett MG, Novy M. Azithromycin (AZI) and antiinflammatory therapy for intraamniotic infection (IAI) with Ureaplasma parvum in a non-human primate model. Reprod Sci. 2007;14(1 Suppl.):65A;(abstract 31)
  28. Sadowsky DW, Reed MD, O'Riordan MA, Duffy LB, Waites KB, Novy M. Azithromycin (AZI) Dose-finding study for treatment of Ureaplasma intraamniotic infection (IAI) in rhesus monkeys. Reprod Sci. 2007;14(1 Suppl.):65A;(abstract 30)
  29. Novy M, Sadowsky DW, Grigsby PL, Sparks KE, Duffy LB, Waites KB. Maternal azithromycin (AZI) therapy for Ureaplasma intraamniotic infection (IAI) prevents advanced fetal lung lesions in rhesus monkeys. Reprod Sci. 2008;15(1 Suppl.):184A;(abstract 438)
  30. Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988;2(8605):240–245
  31. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198:43;e1–5
  32. Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet. 1988;1(8575–6):17–21
  33. Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD. Incidence of invasive Ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage. J Perinatol. 2008;epub ahead of print
  34. Walsh WF, Butler , Coalson , Hensley D, Cassell GH, deLemos RA. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin Infect Dis. 1993;17(Suppl. 1):S158–S162
  35. Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH. Effects of antenatal colonization with Ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res. 2003;54:797–807
  36. Manimtim WM, Hasday D, Hester L, Fairchild KD, Lovchik C, Viscardi RM. Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults. Infect Immun. 2001;69:3906–3915
  37. Viscardi R, Manimtim W, He R, et al. Disordered pulmonary myofibroblast distribution and elastin expression in preterm infants with Ureaplasma urealyticum pneumonitis. Pediatr Dev Pathol. 2006;9:143–151
  38. Crouse DT, Odrezin GT, Cutter GR, et al. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis. 1993;17(Suppl. 1):S122–S130
  39. Pacifico L, Panero A, Roggini M, Rossi N, Bucci G, Chiesa C. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis. 1997;16:579–586
  40. Jobe A. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641–643
  41. Baier R, Loggins J, Kruger TE. Failure of erythromycin to eliminate airway colonization with Ureaplasma urealyticum in very low birth weight infants. BMC Pediatr. 2003;3:10
  42. Waites KB, Sims P, Crouse DT, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J. 1994;13:287–293
  43. Lyon A, McColm , Middlemist L, Fergusson S, McIntosh N, Ross PW. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child. 1998;78:F10–F14
  44. Jonsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr. 1998;87:1079–1084
  45. Matlow A, Th'ng C, Kovach D, Quinn P, Dunn M, Wang E. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. Antimicrob Agents Chemother. 1998;42:1290–1292
  46. Waites KB, Bebear CM, Robertson A, Talkington DF, Kenny GE. Cumitech 34, Laboratory diagnosis of mycoplasmal infections. Washington, DC: American Society for Microbiology; 2001;
  47. Waites KB, Talkington DF, Bebear CM. Mycoplasmas. In:  Truant AL editors. Manual of commercial methods in clinical microbiology. Washington, DC: American Society for Microbiology; 2002;p. 201–224
  48. Mallard K, Schopfer K, Bodmer T. Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods. 2005;60:13–19
  49. Cao X, Jiang Z, Wang Y, Gong R, Zhang C. Two multiplex real-time TaqMan polymerase chain reaction systems for simultaneous detecting and serotyping of Ureaplasma parvum. Diagn Microbiol Infect Dis. 2007;59:109–111

    * The most important references are indicated with an asterisks.

PII: S1744-165X(08)00146-7

doi: 10.1016/j.siny.2008.11.009

Seminars in Fetal & Neonatal Medicine
Volume 14, Issue 4 , Pages 190-199 , August 2009